Submitted:
26 May 2025
Posted:
28 May 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Exact Statistical Evaluation of COVID-19 Vaccination Effectiveness
3. Medical Authorities Are Hiding Data on COVID-19 Vaccination Effectiveness
| Number of cancer | 2017 | 2018 | 2019 | 2020 | 2017-2020 | 2021 |
| 15653 | 16778 | 16873 | 15625 | 16232 (100%) |
17349 (116%) |
|
| +1117 (16%) |
4. Hypothetical Evaluations of COVID-19 Vaccine Effectiveness Have No Scientific Validity and Cannot Be the Guide for Public Health Policy

5. COVID-19 Vaccination Changes the Human Genome and Causes Several Diseases, and Should Be Taken off the Market
6. Conclusions
Acknowledgments
References
- Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293-1302 https://pubmed.ncbi.nlm.nih. 3575. [CrossRef]
- World Health Organization. 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021. 2022. https://www.who.int/news/item/05-05-2022-14. 2020.
- Kislaya I, Machado A, Magalhães S, Rodrigues AP, Franco R, Leite PP, et al. COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: Cohort study based on electronic health records, Portugal, May to 22. Euro Surveill. 2022;27(37):2200697. https://pubmed.ncbi.nlm.nih. 20 July 3611. [CrossRef]
- Wu N, Joyal-Desmarais K, Ribeiro PA, Vieira AM, Stojanovic Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11(5):439-452. a. https://pubmed.ncbi.nlm.nih.gov/36780914/. [CrossRef]
- Savinkina A, Bilinski A, Fitzpatrick M, Paltiel AD, Rizvi Z, Salomon J, et al. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ open. 2022;12(9):e061752. a. https://pubmed.ncbi.nlm.nih.gov/36100306/. [CrossRef]
- Šorli AS, Makovec T, Krevel Z, Gorjup R (2023) Forgotten “Primum Non Nocere” and Increased Mortality after COVID-19Vaccination. Qual Prim Care. 31.06. a. https://www.primescholars.com/articles/forgoen-primum-non-nocere-and-increased-mortality-after--covid19-vaccination.pdf.
- NIJZ – National Institute of Public Health https://nijz.si/en/ (2025).
- Cancer Registry of Republic of Slovenia http://www.slora. 2025.
- Oversight body for the National Health Service in England (NHS) https://www.england.nhs.uk/2024/10/nhs-diagnoses-thousands-more-cancers-as-cases-rise-by-5/. 2024.
- STATISTA https://www.statista.com/statistics/1242449/slovenia-vaccination-against-covid-19-by-date/. 2025.
- Sorli AS (2025). The Discrepancy Between the Number of Saved Lives with COVID-19 Vaccination and Statistics of Our World Data. J Clin Trials. S32:001. https://www.longdom.org/open-access/the-discrepancy-between-the-number-of-saved-lives-with-covid19-vaccination-and-statistics-of-our-world-data.
- Alessandria M, Malatesta G, Di Palmo G, Cosentino M, Donzelli A. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK Office for National Statistics public data. F1000Res. 2025 Feb 20;13:886. PMCID: PMC11868741. 10.12688/f1000research.154058. [CrossRef] [PubMed]
- Our World Data (2025) https://ourworldindata.
- Makovec T, Šorli AS, Gorjup R, Krevel Z, Piberl S. Analysis of COVID-19 vaccination effectiveness. J Vaccines Vaccin. 2020;14(5):530. https://www.walshmedicalmedia.com/open-access/analysis-of-covid19-vaccination-effectiveness.
- Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A. 2021 ;118(21):e2105968118. [CrossRef] [PubMed]
- Young Mi Lee, Daniel Broudy, Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study, Vol 3 Num 2 IJVTPR (2024) https://www.ijvtpr.com/index.php/IJVTPR/article/view/102/291.
- Mead MN, Seneff S, Wolfinger R, Rose J, Denhaerynck K, Kirsch S, McCullough PA. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Cureus. 2024 Jan 24;16(1):e52876. Retraction in: Cureus. 2024 Feb 26;16(2):r137. 10.7759/cureus.r137. PMCID: PMC10810638. https://pubmed.ncbi.nlm.nih.gov/38274635/. [CrossRef] [PubMed]
- M. Nathaniel Mead et.al.,COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1, IJVTPR (2024) https://ijvtpr.com/index.
- M. Nathaniel Mead et.al. COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 (2024) https://ijvtpr.com/index.php/IJVTPR/article/view/104.
- Kim, H.J. , Kim, MH., Choi, M.G. et al. Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea. Mol Psychiatry, 2024. [Google Scholar] [CrossRef]
- Hazan, Sabine MD1; Dave, Sonya PhD2; Barrows, Brad DO1; Borody, Thomas J. MD, PhD, DSc, FACG3. S2099 Persistent Damage to the Gut Microbiome Following Messenger RNA SARS-CoV-2 Vaccine. The American Journal of Gastroenterology 117(10S): p e1429-e1430, October 2022. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).